Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CRW22 human prostate cancer xenograft

Journal of Andrology

Volumn 22, Issue 4, 2001, Pages 537-548

  Gregory, C W ^a   Johnson, R T ^a   Presnell, S C ^a   Mohler, J L ^a   French, F S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen; Apoptosis; Cell cycle; Retinoblastoma

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CELL CYCLE PROTEIN; CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; RETINOBLASTOMA PROTEIN; RNA; TESTOSTERONE PROPIONATE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CASTRATION; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; IMMUNOPRECIPITATION; MALE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; CDC2 PROTEIN KINASE; CDC2-CDC28 KINASES; CELL DIVISION; CYCLIN A; CYCLIN B; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; ORCHIECTOMY; PHOSPHORYLATION; PRECIPITIN TESTS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANDROGEN; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034935259     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1939-4640.2001.tb02213.x     Document Type: Article

References (39)

1. Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
2. Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats
3. Increased cell growth and tumorigenicity in human prostate LNCaP cells by over-expression to cyclin D1
4. pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F
5. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
6. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process
7. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
8. Ten years after: Reclassification of steroid-responsive genes
9. Human androgen receptor expression in prostate cancer following androgen ablation
10. Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction
11. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
12. Rb function in cell-cycle regulation and apoptosis
13. Checkpoints: Controls that ensure the order of cell cycle events
14. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
15. Role of androgens in prostate cancer
16. Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells
17. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability
18. Cancer statistics, 1998
19. Regulation of androgen-dependent prostatic cancer cell growth: Androgen regulation of CDK2, CDK4, and CKI p16 genes
20. Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein
21. Specific enzymatic dephosphorylation of the retinoblastoma protein
22. CWR22: The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar
23. Ordering S phase and M phase in the cell cycle
24. Androgen receptor defects: Historical, clinical, and molecular perspectives
25. Acceleration of the G1/S phase transition by expressions of cyclins D1 and E with an inducible system
26. Regulation of androgen action
27. INK4a
28. Cancer cell cycles
29. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation
30. Preparation of genomic DNA from mammalian tissue
31. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells
32. Microscale autoradiographic method for the qualitative and quantitative analysis of apoptotic DNA fragmentation
33. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
34. CWR22: Androgen-dependent xenograft model derived from a primary human prostatic carcinoma
35. The retinoblastoma tumor suppressor protein
36. Role of cyclins in neuronal differentiation of immortalized hippocampal cells
37. Cyclin D1 is required for S-phase traversal in bovine tracheal myocytes
38. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells
39. CDK-independent activation of estrogen receptor by cyclin D1